Introduction

A class of inherited lysosomal storage diseases known as neuronal ceroid lipofuscinosis (NCL), or Batten disease, is typified by a build-up of autofluorescent lipofuscin in tissues, especially neurons, and progressive neurodegeneration. Based on the age of onset and particular gene mutations, there are four forms of Batten disease:

Early-infantile, Late-infantile, Juvenile, and Adult.

The disruption of lysosomal function resulting from mutations in genes such as CLN1, CLN2, and CLN3 leads to the buildup of undigested substrates, cellular damage, and neurodegeneration. Particular gene mutations are linked to each NCL type.

With an incidence of 2 to 4 per 100,000 live births, batten disease is an uncommon condition that affects people worldwide, regardless of their ethnicity. The most prevalent kind of Batten disease in North America and northern Europe is juvenile (CLN3).¹

Sleep disturbances in batten disease 

Impact on life quality¹

Patients with Batten disease and their families suffer greatly from sleep disturbances, which exacerbate neurological symptoms such as seizures, cognitive decline, and behavioural issues. Both the well-being of the patient and the carer can be enhanced by effective management of sleep disturbances.

Connection to the spread of the illness²

Sleep problems can worsen Batten disease's neurodegenerative processes, which can impact the thalamus and hypothalamus. This can quicken the onset of dementia by raising inflammatory reactions, misfolded protein buildup, and neuronal stress.

Batten disease's pathophysiology of sleep disturbances⁵

Brain areas associated with regulating sleep⁵

The pineal gland, thalamus, hypothalamus, and brainstem all control sleep. Arousal and sleep-wake cycles are regulated by the thalamus and brainstem, while circadian rhythms are maintained by the hypothalamus's suprachiasmatic nucleus (SCN). Batten disease affects these areas, disrupting typical sleep patterns.

The batten disease degeneration of neurones ⁵

As the disease progresses, sleep disturbances are caused by progressive neuronal degeneration in the central nervous system, particularly in the cerebral cortex, cerebellum, and deep brain nuclei.

 Modifications to neurochemistry³ 

Changes in neurotransmitters such as dopamine, serotonin, norepinephrine, and GABA impair sleep regulation and lead to insomnia, excessive daytime sleepiness, and irregular sleep-wake cycles.

Genetic alterations and how they affect sleep⁵

Common mutations in the disease batten DNA²

Important genetic variations consist of:

• CLN1 (PPT1): Inhibits lysosome protein degradation, resulting in infantile NCL
• CLN2 (TPP1): By preventing protein hydrolysis in lysosomes, this gene causes late-infantile NCL
• CLN3: Affects lysosomal function and cellular homeostasis, causing juvenile NCL

 Effect on sleep cycle management⁵

These genes' mutations impair neurochemistry and lysosomal function, which impacts neurotransmitter levels and sleep-regulating brain regions. The result is insomnia and interrupted sleep.

Types of sleep disorders linked to batten disease

Sleeplessness

1. Having Trouble Sleeping²

Patients with insomnia that starts before sleep frequently suffer.

2. Having Trouble Falling asleep³ 

Sleep-wake cycle disruptions are a typical cause of frequent nighttime awakenings.

3. Early Wake-Up Calls²

Due to neurodegeneration and disturbances in the circadian cycle, patients may wake up sooner than intended.

Respiratory problems related to sleep²

1. OSA, or obstructive sleep apnea

OSA is a prevalent symptom of Batten disease and is associated with brainstem neuron loss. It is caused by airway blockage during sleep.

2. Apnea Centralis (CSA)

Though less frequent, CSA is still present and causes problems with brain-to-respiratory muscle communication.

Disorders of the circadian rhythm²

1. Delayed Sleep Phase Syndrome (DSPS)

Individuals who suffer from delayed sleep-wake syndrome (DSPS) sometimes struggle to maintain regular sleep schedules.

2. An irregular sleep-wake pattern

Severe neurodegeneration may alter a patient's brain's internal clock, which in some circumstances results in fragmented sleep over 24 hours.

Sleeplessness²

1. Nighttime Fear

Most likely, disrupted sleep architecture which causes bouts of intense fear and trembling while you're asleep is the source of night terrors.

2. The practice of sleepwalking

Disturbances in motor control during sleep, associated with neurodegeneration, give rise to sleepwalking.

Sleep disorders: clinical evaluation and diagnosis

Questionnaires and sleep history

Compiling thorough sleep histories from carers and patients facilitates the identification of particular sleep problems.⁵

Measurable information on the quality of sleep is provided by instruments such as the Children's Sleep Habits Questionnaire (CSHQ) and the Sleep Disturbance Scale for Children (SDSC).⁴

PSG, or polysomnography

PSG measures physiological markers overnight to provide a comprehensive assessment of sleep disorders.³

PSG can show decreased REM sleep, more arousal, and fragmented sleep, which represent the neurological influence on sleep regulation.⁴

Calligraphy

Actigraphy provides useful long-term sleep monitoring by having a wrist device worn to detect movement and sleep patterns over longer periods.¹

Actigraphy is less invasive than PSG and appropriate for long-term monitoring; nevertheless, it may be less precise in differentiating between sleep phases and may be impacted by motor impairments that are typical of Batten disease.¹

Handling sleep issues in patients with batten disease

Interventions based on medication²

1. The hormone that promotes sleep 

Melatonin controls sleep-wake cycles, improving the quality of sleep.

2. Sedatives under hypnosis

When taken cautiously due to potential side effects, they can improve sleep maintenance and reduce sleep latency.

3. Extra Medication 

Medication for nocturnal seizures and related movement disorders, such as trazodone and antiepileptic drugs, can help patients sleep better.

Behavioural and cognitive interventions

1. Insomnia Cognitive Behavioural Therapy (CBT-I)⁴

To enhance the quality of sleep, CBT-I integrates methods such as relaxation training and sleep restriction.

2. Education on Sleep Hygiene²

Healthy sleep patterns may be established by teaching appropriate sleep habits, such as keeping a regular sleep schedule.

Assistive devices and technology

1. CPAP stands for continuous positive airway pressure.²

For people with sleep apnea, continuous positive airway pressure (CPAP) devices assist in maintaining open airways while they sleep.

2. Phototherapy²

When applied in the morning, light therapy promotes normal sleep patterns and helps to balance circadian cycles.

Using a multidisciplinary approach

1. The function of sleep experts, psychologists, and neurologists³

Comprehensive care is provided by a multidisciplinary team that treats both the medical and psychosocial components of sleep problems.

2. Coordination of Care³

Effective management and individualised care are ensured by coordinated efforts among healthcare professionals.

Research and upcoming projects

Targeting underlying genetic abnormalities is the goal of research on gene therapy and enzyme replacement therapy (ERT) to address sleep disorders.⁵

Novel targets encompass small molecule treatments that modulate autophagy and lysosomal activity, in addition to pathways associated with neuroinflammation and oxidative stress.²

To comprehend the long-term effects of Batten disease and its therapies on sleep problems, long-term study is essential.³

To better management options, further research is required on the impact of medications, circadian rhythm disorders, and different kinds of Batten disease on sleep.⁵

With the use of genetic screening, treatment choices can be customised to maximise therapeutic efficacy and reduce unwanted effects.³

Biomarkers enable early intervention and precise monitoring by predicting the course of an illness, the effectiveness of a medication, and its effects on sleep.²

Conclusion

Neuronal ceroid lipofuscinosis (NCL), another name for Batten disease, is a series of neurodegenerative illnesses that are lethal and result from genetic abnormalities that impair lysosomal storage. The regular operation of lysosomes, which are cellular organelles in charge of decomposing waste products and cellular debris, is interfered with by these genetic anomalies. Cellular malfunction and death are caused by the build-up of undigested materials within lysosomes; this is especially true for neurons.

Sleep disruptions are a primary symptom of Batten disease, and they have a substantial negative influence on quality of life and may hasten the illness's course. Insomnia, disturbed sleep, and excessive daytime drowsiness are common in Batten disease patients, which aggravates other symptoms and raises the illness's overall burden. Batten disease variants are caused by genetic mutations in distinct genes and are characterised by severe sleep disruption.

To create successful management plans, it is essential to comprehend the entire range of sleep-related problems associated with Batten disease.

To manage Batten disease, early identification and management are essential. Early diagnosis enables timely therapy, which can help control symptoms and limit the disease's course. When it comes to treating sleep disorders, which can significantly lower a patient's quality of life, early intervention is crucial.

To create effective therapies and get a deeper understanding of Batten disease and its effects on sleep, further study is necessary. Better diagnosis, more money for research, and better assistance for impacted families are all possible outcomes of more awareness